The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of James Andrea S. since 2024.
This trader's CIK number is 2027010.
At the time of last reporting, James Andrea S. was the Chief Financial Officer of Oncocyte Corp. (stock ticker symbol OCX).
Also see all insider trading activities at Oncocyte Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | OCX | 97,561 | $200,000 | 0 | $0 | 0 | $0 |
| 2024 | OCX | 53,670 | $145,799 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-07 | OCX | Buy | 97,561 | 2.05 | 200,000 |
| 2024-12-05 | OCX | Buy | 20,000 | 2.29 | 45,800 |
| 2024-10-02 | OCX | Buy | 33,670 | 2.97 | 99,999 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by James Andrea S. (Chief Financial Officer of Oncocyte Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.